GILD
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Aggressive Growth
# of Employee: 8,000 / Fiscal Year End: 2016-12-31 / Stock Type: Large Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | NVO | CELG | BIIB | SHPG | VRTX | REGN | ALXN | GRFS | INCY | NKTR | CLRB |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-03-25Quarter4,998,956k813,205k76,269k2,222,587k2,227,410k1,679,871,k83.70%44.50%44.60%
2014-06-25Quarter6,534,943k924,709k102,004k3,650,485k3,655,593k1,664,415,k85.80%55.90%55.90%
2014-09-25Quarter6,041,832k987,306k103,366k2,724,263k2,731,274k1,636,530,k83.70%45.10%45.20%
2014-12-25Quarter7,314,269k1,062,780k130,361k3,461,665k3,486,723k1,601,157,k85.50%47.30%47.70%
2015-03-25Quarter7,594m882m153m4,332m4,333m1,569,000,k88.40%57.00%57.10%
2015-06-25Quarter8,244m998m140m4,497m4,492m1,540,000,k87.90%54.50%54.50%
2015-09-25Quarter8,295m1,064m165m4,592m4,600m1,503,000,k87.20%55.40%55.50%
2015-12-25Quarter8,506m1,062m230m4,685m4,683m1,470,000,k87.50%55.10%55.10%
2016-03-25Quarter7,794m1,193m230m3,567m3,566m1,412,000,k84.70%45.80%45.80%
2016-06-25Quarter7,776m864m227m3,497m3,497m1,355,000,k88.90%45.00%45.00%
2016-12-25Quarter7,320m1,075m265m3,099m3,108m1,325,000,k85.30%42.30%42.50%
2017-03-25Quarter6,505m957m261m2,699m2,702m1,320,000,k85.30%41.50%41.50%
2017-06-25Quarter7,141m1,126m269m3,069m3,073m1,317,000,k84.20%43.00%43.00%
2017-09-25Quarter6,512m1,032m291m2,712m2,718m1,319,000,k84.20%41.60%41.70%
2017-12-25Quarter5,949m1,256m297m-3,836m-3,865m1,319,000,k78.90%-64.50%-65.00%
2018-03-25Quarter5,088m1,001m290m1,539m1,538m1,320,000,k80.30%30.20%30.20%
2018-06-25Quarter5,648m1,196m266m1,819m1,817m1,308,000,k78.80%32.20%32.20%
2018-09-25Quarter5,596m1,086m264m2,099m2,097m1,307,000,k80.60%37.50%37.50%
2018-12-25Quarter5,795m1,570m257m3m3m1,293,000,k72.90%0.10%0.10%
2019-03-25Quarter5,281m957m254m1,968m1,975m1,283,000,k81.90%37.30%37.40%
2019-06-25Quarter5,685m1,000m248m1,875m1,880m1,277,000,k82.40%33.00%33.10%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-03-25Quarter51.91%8.46%100.61%94.91%94.53%-6.60%5.62%28.09%28.03%
2015-06-25Quarter26.15%7.93%37.25%23.19%22.88%-7.47%2.45%-2.50%-2.50%
2015-09-25Quarter37.29%7.77%59.63%68.56%68.42%-8.16%4.18%22.84%22.79%
2015-12-25Quarter16.29%-0.07%76.43%35.34%34.31%-8.19%2.34%16.49%15.51%
2016-03-25Quarter2.63%35.26%50.33%-17.66%-17.70%-10.01%-4.19%-19.65%-19.79%
2016-06-25Quarter-5.68%-13.43%62.14%-22.24%-22.15%-12.01%1.14%-17.43%-17.43%
2016-12-25Quarter-11.75%1.03%60.61%-32.51%-32.43%-11.84%-2.18%-23.65%-23.42%
2017-03-25Quarter-23.52%-9.89%13.48%-42.39%-42.30%-10.20%-2.51%-24.68%-24.68%
2017-06-25Quarter-8.38%-5.62%16.96%-13.96%-13.83%-6.73%-0.59%-6.11%-6.11%
2017-09-25Quarter-16.26%19.44%28.19%-22.45%-22.28%-2.66%-5.29%-7.56%-7.33%
2017-12-25Quarter-18.73%16.84%12.08%-223.78%-224.36%-0.45%-7.50%-252.48%-252.94%
2018-03-25Quarter-21.78%4.60%11.11%-42.98%-43.08%0.00%-5.86%-27.23%-27.23%
2018-06-25Quarter-20.91%6.22%-1.12%-40.73%-40.87%-0.68%-6.41%-25.12%-25.12%
2018-09-25Quarter-14.07%5.23%-9.28%-22.60%-22.85%-0.91%-4.28%-9.86%-10.07%
2018-12-25Quarter-2.59%25.00%-13.47%-100.08%-100.08%-1.97%-7.60%-100.16%-100.15%
2019-03-25Quarter3.79%-4.40%-12.41%27.88%28.41%-2.80%1.99%23.51%23.84%
2019-06-25Quarter0.66%-16.39%-6.77%3.08%3.47%-2.37%4.57%2.48%2.80%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter18,887m56,977m38,090m20,445m9,219m28,871m.496.451
2017-03-25Quarter20,441m57,701m37,260m21,424m8,282m28,978m.549.387
2017-06-25Quarter22,677m60,263m37,586m28,592m8,492m29,094m.603.297
2017-09-25Quarter24,845m64,662m39,817m35,317m9,597m30,220m.624.272
2017-12-25Quarter20,442m70,283m49,841m31,823m11,635m38,206m.410.366
2018-03-25Quarter20,591m65,381m44,790m30,258m10,670m34,120m.460.353
2018-06-25Quarter21,672m65,355m43,683m32,728m10,912m32,771m.496.333
2018-09-25Quarter22,861m64,306m41,444m34,918m10,116m31,328m.552.290
2018-12-25Quarter21,387m63,675m42,288m35,836m10,605m31,683m.506.296
2019-03-25Quarter21,951m62,837m40,886m34,024m9,397m31,489m.537.276

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter8.23%23.35%30.85%55.65%26.21%32.33%-17.34%-18.85%
2018-03-25Quarter0.73%13.31%20.21%41.23%28.83%17.74%-16.21%-8.79%
2018-06-25Quarter-4.43%8.45%16.22%14.47%28.50%12.64%-17.74%12.12%
2018-09-25Quarter-7.99%-0.55%4.09%-1.13%5.41%3.67%-11.54%6.62%
2018-12-25Quarter4.62%-9.40%-15.15%12.61%-8.85%-17.07%23.41%-19.13%
2019-03-25Quarter6.60%-3.89%-8.72%12.45%-11.93%-7.71%16.74%-21.81%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note